Outcomes of renal transplantation in recipients with Wegener's granulomatosis

Clinical Transplantation

Volumn 25, Issue 3, 2011, Pages 380-387

  Shen, Jenny ^a   Gill, Jagbir ^b   Shangguan, Muyun ^a   Sampaio, Marcelo S ^a,c   Bunnapradist, Suphamai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

Outcomes; Renal transplantation; Wegener's granulomatosis

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; DEATH; DELAYED GRAFT FUNCTION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HAZARD RATIO; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS; YOUNG ADULT;

EID: 79958707697     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01248.x     Document Type: Article

References (26)

1. Westman KW, Bygren PG, Olsson H, Ranstam J, Wieslander J. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998: 9: 842.
2. Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 1998: 9: 1258.
3. Aasarod K, Iversen BM, Hammerstrom J, Bostad L, Vatten L, Jorstad S. Wegener's granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 2000: 15: 611.
4. Koldingsnes W, Nossent H. Predictors of survival and organ damage in Wegener's granulomatosis. Rheumatology (Oxford) 2002: 41: 572.
5. Hogan SL, Falk RJ, Chin H et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 2005: 143: 621.
6. Falk RJ, Hogan S, Carey TS, Jennette JC. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 1990: 113: 656.
7. Moroni G, Torri A, Gallelli B et al. The long-term prognosis of renal transplant in patients with systemic vasculitis. Am J Transplant 2007: 7: 2133.
8. Wrenger E, Pirsch JD, Cangro CB et al. Single-center experience with renal transplantation in patients with Wegener's granulomatosis. Transpl Int 1997: 10: 152.
9. Haubitz M, Kliem V, Koch KM et al. Renal transplantation for patients with autoimmune diseases: single-center experience with 42 patients. Transplantation 1997: 63: 1251.
10. Briggs JD, Jones E. Renal transplantation for uncommon diseases. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 1999: 14: 570.
11. Schmitt WH, Van Der Woude FJ. Organ transplantation in the vasculitides. Curr Opin Rheumatol 2003: 15: 22.
12. Gera M, Griffin MD, Specks U, Leung N, Stegall MD, Fervenza FC. Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression. Kidney Int 2007: 71: 1296.
13. Geetha D, Seo P. Renal transplantation in the ANCA-associated vasculitides. Am J Transplant 2007: 7: 2657.
14. Schmitt WH, Haubitz M, Mistry N, Brunkhorst R, Erbsloh-Moller B, Gross WL. Renal transplantation in Wegener's granulomatosis. Lancet 1993: 342: 860.
15. Stegeman CA, Tervaert JW, Van Son WJ, Tegzess AM. Necrotizing glomerulonephritis associated with antimyeloperoxidase antibodies in a renal transplant recipient with renal failure of unknown origin. Nephrol Dial Transplant 1994: 9: 839.
16. Rosenstein ED, Ribot S, Ventresca E, Kramer N. Recurrence of Wegener's granulomatosis following renal transplantation. Br J Rheumatol 1994: 33: 869.
17. Haubitz M, Olbricht CJ, Maschek H, Frei U, Koch KM. Lethal relapse of Wegener's disease 4years after successful kidney transplantation. Nephron 1995: 71: 118.
18. Frasca GM, Neri L, Martello M, Sestigiani E, Borgnino LC, Bonomini V. Renal transplantation in patients with microscopic polyarteritis and antimyeloperoxidase antibodies: report of three cases. Nephron 1996: 72: 82.
19. Grotz W, Wanner C, Rother E, Schollmeyer P. Clinical course of patients with antineutrophil cytoplasm antibody positive vasculitis after kidney transplantation. Nephron 1995: 69: 234.
20. Rostaing L, Modesto A, Oksman F, Cisterne JM, Le Mao G, Durand D. Outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis following cadaveric kidney transplantation. Am J Kidney Dis 1997: 29: 96.
21. Nyberg G, Akesson P, Norden G, Wieslander J. Systemic vasculitis in a kidney transplant population. Transplantation 1997: 63: 1273.
22. Fan SL, Lewis KE, Ball E, Dodd S, Raftery MJ, Yaqoob MM. Recurrence of Wegener's granulomatosis 13years after renal transplantation. Am J Kidney Dis 2001: 38: E32.
23. Elmedhem A, Adu D, Savage CO. Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation. Nephrol Dial Transplant 2003: 18: 1001.
24. Nachman PH, Segelmark M, Westman K et al. Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis. Kidney Int 1999: 56: 1544.
25. Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant 2008: 8: 593.
26. Port FK, Merion RM, Goodrich NP, Wolfe RA. Recent trends and results for organ donation and transplantation in the United States, 2005. Am J Transplant 2006: 5 Pt 6: 1095.